Literature DB >> 13398616

Heterogeneity in extent of the combining regions of human antidextran.

E A KABAT.   

Abstract

Entities:  

Keywords:  IMMUNITY

Mesh:

Year:  1956        PMID: 13398616

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  26 in total

1.  THE ANTIGENICITY OF SOME SYNTHETIC POLY-IMINOACIDS. I. ANTIGENIC PROPERTIES OF POLY-L-PROLINE.

Authors:  H E JASIN; L E GLYNN
Journal:  Immunology       Date:  1965-01       Impact factor: 7.397

2.  Immunofluorescence.

Authors:  A H COONS
Journal:  Public Health Rep       Date:  1960-10       Impact factor: 2.792

3.  Isoagglutinins associated with ABO erythroblastosis.

Authors:  S KOCHWA; R E ROSENFIELD; L TALLAL; L R WASSERMAN
Journal:  J Clin Invest       Date:  1961-05       Impact factor: 14.808

4.  Quantitative aspects of the reaction between insulin and insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

5.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

6.  Immunochemistry of the pneumococcal types II. V. and VI. I. The relation of Type VI to Type II and other correlations between chemical constitution and precipitation in antisera to type VI.

Authors:  M HEIDELBERGER; P A REBERS
Journal:  J Bacteriol       Date:  1960-08       Impact factor: 3.490

7.  THE SIGNIFICANCE OF THE PROTEIN CARRIER IN THE STIMULATION OF DNA SYNTHESIS BY HAPTEN-PROTEIN CONJUGATES IN THE SECONDARY RESPONSE.

Authors:  R W DUTTON; H N BULMAN
Journal:  Immunology       Date:  1964-01       Impact factor: 7.397

8.  Preparation and characterization of the isomaltodextrins.

Authors:  J R TURVEY; W J WHELAN
Journal:  Biochem J       Date:  1957-09       Impact factor: 3.857

9.  Structural requirements of sugars as antagonists of the vascular response to dextran in rat skin.

Authors:  R H Poyser; G B West
Journal:  Br J Pharmacol Chemother       Date:  1968-02

10.  SPECIFIC FRACTIONATION OF HUMAN ANTIDEXTRAN ANTIBODIES. II. ASSAY OF HUMAN ANTIDEXTRAN SERA AND SPECIFICALLY FRACTIONATED PURIFIED ANTIBODIES BY MICROCOMPLEMENT FIXATION AND COMPLEMENT FIXATION INHIBITION TECHNIQUES.

Authors:  J GELZER; E A KABAT
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.